Apols, NAV less 1% is currently c. 72p, not 70p.
Anyone else thinking of taking the cash option? Would be NAV less 1%, so currently around 70p. Slightly more than the 68.8p that will go towards buying HHI shares currently. I suspect the gap will narrow or disappear completely before decision day but worth keeping an eye on?
Crusty, fwiw I've invested in a whole gaggle of turkeys myself (this, DDDD, HAWK, FDI, VOG, CTT, HEIQ, TRP) but fortunately found a couple of diamonds that have kept my head above water. Moral of the story seems to be - don't follow Crusty/Krusty when planning an investment! Best of luck to all invested here & elsewhere. K
#kievsky
Kievski has already claimed the 8.5m (7 Dec) unless there were 2 trades of 8.5m?
Not sure what the driver is for the current re-rate but whatever it is it's very welcome.
Interesting to look back at one of your posts on 30th October StarBright. You speculated about companies in the US being tempted to come in for GSF whilst there is such a huge discount to the NAV. It'll certainly be interesting to see if Nidec add to their holding in the open market, they'll be able to pick up shares much more cheaply than the 112.9p paid for the subscription shares. Really exciting development for shareholders here IMV.
Thanks gixer, I've messaged them. It's not for me as it happens but one of the people I've recommended to take Fruitflow over the years.
Doesn't seem to have improved your stress levels though colbalt. Oh, & Fruitflow's not a blood thinner either fyi.
I know there has been discussion about this on here some time ago so can anyone remind me? What's the view on taking Fruitflow if you're on a statin?
Thanks.
Just watching the Investor Meet Company presentation from GSF. NAV has dropped to 112.9p at period-end due mainly to higher inflation and increased discount rate due to interest rate rises. I think it much less likely now to achieve the hoped-for 8p dividend in the current year. 7.5p yield still represents a good return on 85.3p share price though. Apart from very weak UK pricing, as previously indicated, all other reporting appears positive, particularly in terms of revenue generation from US assets.
Moving to bi-annual dividend payment though, so we probably won't see another payment until Sep/Oct.
Absolutely damofarl, or 13 years as the company has declared it has sight of future secure income. It means trying to find another decent, reliable dividend payer to invest in, in an environment where many are putting up the shutters. Life gets harder & harder every day for income seekers in the London markets. Maybe a white knight will appear to take the assets on, but no-one has come in for VSL or RMII and they've got very similar stories to tell. Let's see.
The other thing that gets me about this, and other similar scenarios, is the large shareholders pushing for liquidation so they can show a quick profit to cover their losses elsewhere. I'm not as pessimistic about the future as many are, so I believe (perhaps naively) things will look much better in 6 - 12 months time. Surely they can ride that out?
It's not the first Trek. In my portfolio alone this is also the fate of VSL and RMII. HDIV is being subsumed within HHI and there are plenty of others that I'm aware of. It makes me sick to my stomach, decent Trusts/companies that are well run, paying a reliable dividend but just can't survive the NAV gap. They're basically being strangled by the UK market at a time when they should be flag-flying leaders of the recovery. It's beyond frustrating, it really is. We need, at the very least, a clear signal from the BoE that interest rates have peaked and are likely to start falling next year, otherwise this carnage will be repeated all over the place.
Re TMI/TMIP, as far as I'm aware it's the same scenario as the old RDSA/RDSB shares. It's been this way since trading began nearly 4 years ago. There's been a close correlation between the two all along, accepting the currency fluctuations.
If you want to buy in £ and receive your dividends in £ then you buy TMIP.
If you want to buy in $ and receive your dividend in $ then you buy TMI.
Thank you for taking the time and trouble to post your message citizen, it is very much appreciated by both of us. Although my wife's condition has not progressed to this extent (fortunately), I will have a close look at the findings as it does say there is the possibility for earlier intervention at some point.
Thanks again, & kind regards.
Mr & Mrs K
Absolutely Sam, & as you say looking very promising for next reporting period. Just need a global trade uplift now and we should be set fair here for a while at least. Also the dividend must be about 10% at the current exchange rate, so in effect we could get our investment back within a decade - not to be sniffed at!
$120m loss for the first 6 months. Not great but probably about what had been expected. Doesn't help when the stated priority of the company is reducing debt. Also explains why so many vessels are having to be sold to meet debt reduction targets. On the positive side, looks like the second half has begun much better as far as daily rates are concerned, and as most vessels are on very short charter durations, plenty of opportunity to take advantage of any improvements as they appear. Good to see the average fleet age reducing too, bodes well for the future. All in all, not too bad - hope for better things at full time. K
Thanks for this citizen79, my wife is currently receiving treatment for MM and so obviously this has particular significance for me. Although this will probably be too late for her, given the length of time these trials take to arrange, It would be wonderful to think that at some point SAR could play a part in improving the quality/quantity of life for future sufferers. K
Excellent results, dividend increased and solid market reaction. Full year earnings forecast "modestly ahead of market consensus". What's not to like here?